mweitzner Posted - 49 minutes ago

$AMGN really surprised the ritualistic closing dump didnt turn it red. Chart looks identically every day this week. Grinds up all day dumps at bell.

NEWBIGTECH Posted - 2 hours ago

$ENSC is looking for a partner to help with Opioid Addiction. Has FDA Approval on for its PF614-MPAR® technology. SO Does it get $JNJ $AMGN $PFE or $RHHBY .. Get the word out, maybe competing Bids for this Technology. Who has the made an offer? Are they aware that $ENSC is the only Drug company with this technology?

JohK Posted - 2 hours ago

$AMGN Don't get why this stock has struggled so much? One of my worst positions. Add or hold?

BluntForceOptions Posted - 2 hours ago

$SLRN Food for thought: I don't invest in co's based solely on T/O speculation, but considering Acelyrin's laughably low 418M MC & -307M EV, it's clear there's a unique opportunity for those looking to expand. With a BOD rich in M&A experience, it's definitely not out of the question to think major players who missed out on $HZNP to $AMGN could be taking a serious look. Acelyrin boasts robust, late-stage programs and a promising anti-cKIT monoclonal antibody (w/a lead indication for Chronic Urticaria (CU), a market expected to grow to greater than $5.8B globally by 2030), that could be exactly what co's like $SNY need to bolster their portfolios. IMO, the combo of Acelyrin's advanced PL and obvious undervaluation forms a rare alignment that could spark interest from larger bios seeking significant, strategic additions at a value-driven entry point. Time will tell, but in the meantime, I remain extremely bullish and anticipating a strong reversal in the near future. Blessings to all.

profit_guru Posted - 5 hours ago

$AMGN - might close above 275 if rally continues…imo

DonCorleone77 Posted - 5 hours ago

$AMGN Amgen announces imminent submission of MAA to EMA for teprotumumab Amgen announced the imminent submission of a Marketing Authorization Application, or MAA, to the European Medicines Agency, or EMA, for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1 receptor, or IGF-1R, for the treatment of moderate to severe Thyroid Eye Disease, or TED, in adults. TED is a serious, progressive, debilitating and potentially vision-threatening autoimmune disease that can cause proptosis, diplopia, eye pain, redness and swelling.1 If approved, teprotumumab would be the first and only medicine approved for TED in the European Union. The MAA is supported by multiple well-controlled clinical studies - a Phase 2 clinical study NCT01868997, Phase 3 confirmatory clinical study OPTIC NCT03298867, a Phase 4 study NCT04583735, and a Phase 3 clinical trial in Japan OPTIC-J, jRCT2031210453 - providing statistically significant and clinically meaningful improvements across multiple facets of TED, including in proptosis and diplopia, among the 287 total patients studied. Additionally, the studies assessed TED signs and symptoms such as pain, inflammation, redness and functional vision. Clinical improvements were seen in proptosis as early as six weeks, with continued improvement across the 24-week treatment period.2 Teprotumumab has a well-established safety profile.

profit_guru Posted - 7 hours ago

$AMGN - going lot higher from here…way oversold…imo

Stock_Titan Posted - 7 hours ago

$AMGN AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY https://www.stocktitan.net/news/AMGN/amgen-to-submit-teprotumumab-marketing-authorization-application-to-qpzxs0tckyri.html

mweitzner Posted - 1 day ago

$AMGN complete rejection of 274. Bulls worn out. Stock heading back down to 260.

Nullified Posted - 1 day ago

$AMGN news based market strikes again.

Preacherclint10 Posted - 1 day ago

$AMGN $JNJ $MNKD up up up! Growth!

RedBear Posted - 1 day ago

$AMGN $BMY $GILD $PFE reiterating garbage status

Arooba2 Posted - 1 day ago

$MNKD $JNJ $AMGN i like this way Simple and visual more please

Arooba2 Posted - 1 day ago

$MRK will it boost us $SCHD $AMGN $LABU

clan Posted - 1 day ago

$MNKD $JNJ $AMGN Don't get your investment advice from an Uber driver. Hear what the pros are saying ...

mweitzner Posted - 2 days ago

$AMGN 2 straight days battling for $274

StockDr1 Posted - 2 days ago

$AMGN Textbook gap fill, we are now set up for a high volume follow through day….. most likely next week with positive earnings . Very bullish

Simon77 Posted - 2 days ago

$AMGN what’s the news?

DefenseMania Posted - 3 days ago

$GILD now owns 32% of the RCUS share float also picked up a 2nd seat on the BOD hmmmmmmm $ABBV $AMGN $AZN $PFE

mweitzner Posted - 4 days ago

$AMGN approaching $273 again where it bounced off several times past couple weeks which is also now roughly the 200ema and 20sma. Let’s see what happens!

lextrading Posted - 5 days ago

$AMGN I'm only interested if this falls to the lower green trendline near ~$230.

GemsBot Posted - 6 days ago

1 of 11 $AAPL $AMGN $AMZN Daily and 30 min charts of the DJIA Components with the SSI indicator, a proprietary indicator based exclusively on the eSignal platform, are posted here weekends … see 2/11

Arooba2 Posted - 6 days ago

$AMGN is this nove sustainable? $CVX I want to enter again

DefenseMania Posted - 6 days ago

$AMGN about to be acquired ?

Options_Destroyer Posted - 1 week ago

$BITO $AMGN $TLRY Best performing on list today.. keepers

mweitzner Posted - 1 week ago

$AMGN finally the strong reversal we have been waiting for. An opening dip and then rocket up on good volume. It has been working hard trying to regain the 200ma on the 30min. It is nice being solid green between this and UNH on a red market day. Let’s see how she closes here.

Stocksrunner Posted - 1 week ago

📊🔍 Friday Market Insights 🔍📊 Here's a peek into short interest changes: $AMGN Short percent of float down by 5.77%! 📉 $UNH Short percent of float rises by 6.33%! 📈 $MUSA Short percent of float dips by 7.03%! 📉 $HLT Short percent of float climbs by 6.72%! 📈 And $GTLB Short percent of float up by 27.76%! 📈 GitLab's getting attention, but are traders betting against it? https://stocksrunner.com/symbol/GTLB Stay informed, Traders! 📈💼

EPR53167 Posted - 1 week ago

$AMGN the earnings run begins in earnest…..

BobGood Posted - 1 week ago

$AMRN I was doing a small DD within my capabilities reg Lp(a)... My wild guess is $AMGN may be interested in $AMRN because of CVD +Lp(a). So, probably they may (or can) buy $AMRN for peanuts based on their revenues w tons of medicines, tons of pipelines (mostly ph 3), cash rich big pharma, etc.. I wouldn't be surprised even if $AMGN ($262 0n 4/18) exchange for their share e.g., 1:25 or 1:30 etc... For example, 1:25 means, $AMRN will get $10.48/sh 1:30 means, $AMRN will get $8.73/sh 1:35 means, $AMRN will get $7.45/sh etc... Under worst scenario, under 1:35, $AMGN outstanding 536M shares will be increased by 11 M shares to 547M which is about 2% increase!!... just my wishful opinion. Anyways I am okay for any $8~10/sh at this stage although $AMRN might be much worthy in long term ! GLTA Bullish

BobGood Posted - 1 week ago

@JRoon71 Sorry for the delayed response as I am on travel now.. IMHO, you are mistaken.. If I know correctly, $AMRN needn't to run a trail for Lp(a) as this is an additional indication found out during detailed analysis on the already approved Reduce IT trial.. so, try to google out, you will find it's a matter of procedure to get FDA approval. That's why I am sure $AMGN might be interested in $AMRN but 🤞🤞🤞 GLTA